Mitotic kinesin inhibitor

A mitotic kinesin Eg5 inhibitor which comprises a thiadiazoline derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient: [wherein R 1 represents a hydrogen atom and the like, R 2 represents a hydrogen atom, -C(=W)R 6 (wherein W represe...

Full description

Saved in:
Bibliographic Details
Main Authors CHIKARA MURAKATA, RYUICHIRO NAKAI, KAZUHITO AKASAKA, YUSHI KITAMURA, YOSHINORI YAMASHITA, KAZUHIKO KATO, YOJI INO
Format Patent
LanguageEnglish
Published 18.03.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A mitotic kinesin Eg5 inhibitor which comprises a thiadiazoline derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient: [wherein R 1 represents a hydrogen atom and the like, R 2 represents a hydrogen atom, -C(=W)R 6 (wherein W represents an oxygen atom or a sulfur atom, and R 6 represents substituted or unsubstituted lower alkyl and the like) and the like, R 3 represents -C(=Z)R 19 (wherein Z represents an oxygen atom or a sulfur atom, and R 19 represents substituted or unsubstituted lower alkyl and the like) and the like, R 4 represents substituted or unsubstituted lower alkyl and the like, and R 5 represents substituted or unsubstituted aryl and the like] and the like are provided.
AbstractList A mitotic kinesin Eg5 inhibitor which comprises a thiadiazoline derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient: [wherein R 1 represents a hydrogen atom and the like, R 2 represents a hydrogen atom, -C(=W)R 6 (wherein W represents an oxygen atom or a sulfur atom, and R 6 represents substituted or unsubstituted lower alkyl and the like) and the like, R 3 represents -C(=Z)R 19 (wherein Z represents an oxygen atom or a sulfur atom, and R 19 represents substituted or unsubstituted lower alkyl and the like) and the like, R 4 represents substituted or unsubstituted lower alkyl and the like, and R 5 represents substituted or unsubstituted aryl and the like] and the like are provided.
Author YOJI INO
RYUICHIRO NAKAI
YOSHINORI YAMASHITA
CHIKARA MURAKATA
KAZUHITO AKASAKA
YUSHI KITAMURA
KAZUHIKO KATO
Author_xml – fullname: CHIKARA MURAKATA
– fullname: RYUICHIRO NAKAI
– fullname: KAZUHITO AKASAKA
– fullname: YUSHI KITAMURA
– fullname: YOSHINORI YAMASHITA
– fullname: KAZUHIKO KATO
– fullname: YOJI INO
BookMark eNrjYmDJy89L5WSQ9M0syS_JTFbIzsxLLc7MU8jMy8hMAooV8TCwpiXmFKfyQmluBhU31xBnD93Ugvz41OKCxOTUvNSSeMdQIwMDEyNjA3NLSycnI2MilQEA2rIl8g
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2004230799BB2
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2004230799BB23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:00:23 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2004230799BB23
Notes Application Number: AU20040230799
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100318&DB=EPODOC&CC=AU&NR=2004230799B2
ParticipantIDs epo_espacenet_AU2004230799BB2
PublicationCentury 2000
PublicationDate 20100318
PublicationDateYYYYMMDD 2010-03-18
PublicationDate_xml – month: 03
  year: 2010
  text: 20100318
  day: 18
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies FUJIFILM CORPORATION
KYOWA HAKKO KIRIN CO., LTD
RelatedCompanies_xml – name: KYOWA HAKKO KIRIN CO., LTD
– name: FUJIFILM CORPORATION
Score 2.759154
Snippet A mitotic kinesin Eg5 inhibitor which comprises a thiadiazoline derivative represented by the general formula (I) or a pharmacologically acceptable salt...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Mitotic kinesin inhibitor
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100318&DB=EPODOC&locale=&CC=AU&NR=2004230799B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTROBbaTjcx1Tc3MjYEdFAsz3USTNDPdFDMjg5SkFGAVCTnt08_MI9TEK8I0gokhB7YXBnxOaDn4cERgjkoG5vcScHldgBjEcgGvrSzWT8oECuXbu4XYuqhBe8eG4DSq5uJk6xrg7-LvrObsDOxJqvkFgRdcgNY8W1o6AQtsVlBDGnTSvmuYE2hfSgFypeImyMAWADQvr0SIgSk1T5iB0xl295owA4cvdMobyITmvmIRBklfYPYDRrRCNmitemaeQmZeRmYSUKxIlEHFzTXE2UMXaEc83EvxjqFIDnIyMhZjYAH29lMlGBQsLdJSkxJNjE0sQY13o5SkZNOU1OTElCRjYB_YItFIkkEWr1FSBOSlGbggE-DGuoYWMgwsJUWlqbLAerUkSQ4cHACWSXnd
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTROBbaTjcx1Tc3MjYEdFAsz3USTNDPdFDMjg5SkFGAVCTnt08_MI9TEK8I0gokhB7YXBnxOaDn4cERgjkoG5vcScHldgBjEcgGvrSzWT8oECuXbu4XYuqhBe8eG4DSq5uJk6xrg7-LvrObsDOxJqvkFgRdcgNY8W1o6AQtsVnPQ-bygxlOYE2hfSgFypeImyMAWADQvr0SIgSk1T5iB0xl295owA4cvdMobyITmvmIRBklfYPYDRrRCNmitemaeQmZeRmYSUKxIlEHFzTXE2UMXaEc83EvxjqFIDnIyMhZjYAH29lMlGBQsLdJSkxJNjE0sQY13o5SkZNOU1OTElCRjYB_YItFIkkEWr1FSBOTlGTg9Qnx94n08_bylGbggk-HGuoYWMgwsJUWlqbLAOrYkSQ4cNABxTXzK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Mitotic+kinesin+inhibitor&rft.inventor=CHIKARA+MURAKATA&rft.inventor=RYUICHIRO+NAKAI&rft.inventor=KAZUHITO+AKASAKA&rft.inventor=YUSHI+KITAMURA&rft.inventor=YOSHINORI+YAMASHITA&rft.inventor=KAZUHIKO+KATO&rft.inventor=YOJI+INO&rft.date=2010-03-18&rft.externalDBID=B2&rft.externalDocID=AU2004230799BB2